ブックタイトル血管内留置カテーテル由来感染の予防のためのCDCガイドライン 2011|株式会社メディコン

ページ
69/74

このページは 血管内留置カテーテル由来感染の予防のためのCDCガイドライン 2011|株式会社メディコン の電子ブックに掲載されている69ページの概要です。
秒後に電子ブックの対象ページへ移動します。
「ブックを開く」ボタンをクリックすると今すぐブックを開きます。

概要

血管内留置カテーテル由来感染の予防のためのCDCガイドライン 2011|株式会社メディコン

322. Fontaine PJ. Performance of a new softening expanding midline catheter in home intravenous therapypatients. J Intraven Nurs 1991; 14:91?9.323. Harwood IR, Greene LM, Kozakowski-Koch JA, Rasor JS. New peripherally inserted midline catheter: abetter alternative for intravenous antibiotic therapy in patients with cystic fibrosis. Pediatr Pulmonol 1992;12:233?9.324. Mermel LA, Parenteau S, Tow SM. The risk of midline catheterization in hospitalized patients. A prospectivestudy. Ann Intern Med 1995; 123:841?4.325. Uldall PR, Merchant N, Woods F, Yarworski U, Vas S. Changing subclavian haemodialysis cannulas toreduce infection. Lancet 1981; 1:1373.326. Cook D, Randolph A, Kernerman P, et al. Central venous catheter replacement strategies: a systematicreview of the literature. Crit Care Med 1997; 25:1417?24.327. Cobb DK, High KP, Sawyer RG, et al. A controlled trial of scheduled replacement of central venous andpulmonary-artery catheters. N Engl J Med 1992; 327:1062?8.328. Beathard GA. Management of bacteremia associated with tunneled-cuffed hemodialysis catheters. J AmSoc Nephrol 1999; 10:1045?9.329. Duszak R Jr., Haskal ZJ, Thomas-Hawkins C, et al. Replacement of failing tunneled hemodialysis cathetersthrough pre-existing subcutaneous tunnels: a comparison of catheter function and infection rates for denovo placements and over-the-wire exchanges. J Vasc Interv Radiol 1998; 9:321?7.330. Robinson D, Suhocki P, Schwab SJ. Treatment of infected tunneled venous access hemodialysis catheterswith guidewire exchange. Kidney Int 1998; 53:1792?4.331. Saad TF. Bacteremia associated with tunneled, cuffed hemodialysis catheters. Am J Kidney Dis 1999;34:1114?24.332. Ainsworth S, Clerihew L, McGuire W. Percutaneous central venous catheters versus peripheral cannulaefor delivery of parenteral nutrition in neonates. Cochrane Database of Systematic Reviews 2007; Issue 3.Art. No.: CD004219. DOI: 10.1002/14651858.CD004219. pub3.333. Shah PS, Kalyn A, Satodia P, et al. A randomized, controlled trial of heparin versus placebo infusion toprolong the usability of peripherally placed percutaneous central venous catheters (PCVCs) in neonates:the HIP (Heparin Infusion for PCVC) study. Pediatrics 2007; 119:e284?91.334. Jaar BG, Hermann JA, Furth SL, Briggs W, Powe NR. Septicemia in diabetic hemodialysis patients:comparison of incidence, risk factors, and mortality with nondiabetic hemodialysis patients. Am J Kidney Dis2000; 35:282?92.335. Powe NR, Jaar B, Furth SL, Hermann J, Briggs W. Septicemia in dialysis patients: incidence, risk factors,and prognosis. Kidney Int 1999; 55:1081?90.336. Hoen B, Paul-Dauphin A, Hestin D, Kessler M. EPIBACDIAL: a multicenter prospective study of risk factorsfor bacteremia in chronic hemodialysis patients. J Am Soc Nephrol 1998; 9:869?76.337. Blot F, Chachaty E, Raynard B, Antoun S, Bourgain JL, Nitenberg G. Mechanisms and risk factors forinfection of pulmonary artery catheters and introducer sheaths in cancer patients admitted to an intensivecare unit. J Hosp Infect 2001; 48:289?97.338. Kac G, Durain E, Amrein C, Herisson E, Fiemeyer A, Buu-Hoi A. Colonization and infection of pulmonaryartery catheter in cardiac surgery patients: epidemiology and multivariate analysis of risk factors. Crit CareMed 2001; 29:971?5.339. Chen YY, Yen DH, Yang YG, Liu CY, Wang FD, Chou P. Comparison between replacement at 4 days and 7days of the infection rate for pulmonary artery catheters in an intensive care unit. Crit Care Med 2003;31:1353?8.66